nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—ABCC8—type 2 diabetes mellitus	0.064	0.587	CbGaD
Tolazamide—Sulfonylurea Compounds—Chlorpropamide—type 2 diabetes mellitus	0.0612	0.21	CiPCiCtD
Tolazamide—Sulfonylurea Compounds—Glimepiride—type 2 diabetes mellitus	0.0612	0.21	CiPCiCtD
Tolazamide—Sulfonylurea Compounds—Tolbutamide—type 2 diabetes mellitus	0.0612	0.21	CiPCiCtD
Tolazamide—Sulfonylurea Compounds—Glipizide—type 2 diabetes mellitus	0.0612	0.21	CiPCiCtD
Tolazamide—Glipizide—type 2 diabetes mellitus	0.0491	0.217	CrCtD
Tolazamide—Gliclazide—type 2 diabetes mellitus	0.0491	0.217	CrCtD
Tolazamide—Tolbutamide—type 2 diabetes mellitus	0.0491	0.217	CrCtD
Tolazamide—Sulfonylurea Compounds—Glyburide—type 2 diabetes mellitus	0.0464	0.159	CiPCiCtD
Tolazamide—KCNJ11—type 2 diabetes mellitus	0.0451	0.413	CbGaD
Tolazamide—Chlorpropamide—type 2 diabetes mellitus	0.0449	0.198	CrCtD
Tolazamide—Glyburide—type 2 diabetes mellitus	0.034	0.15	CrCtD
Tolazamide—KCNJ1—Glimepiride—type 2 diabetes mellitus	0.0208	0.126	CbGbCtD
Tolazamide—KCNJ1—Tolbutamide—type 2 diabetes mellitus	0.0134	0.0811	CbGbCtD
Tolazamide—ABCC8—Glimepiride—type 2 diabetes mellitus	0.0113	0.0684	CbGbCtD
Tolazamide—ABCC8—Glipizide—type 2 diabetes mellitus	0.0103	0.0626	CbGbCtD
Tolazamide—KCNJ11—Glimepiride—type 2 diabetes mellitus	0.00977	0.0591	CbGbCtD
Tolazamide—ABCC8—Gliclazide—type 2 diabetes mellitus	0.00961	0.0582	CbGbCtD
Tolazamide—ABCC8—Repaglinide—type 2 diabetes mellitus	0.00903	0.0547	CbGbCtD
Tolazamide—KCNJ11—Glipizide—type 2 diabetes mellitus	0.00893	0.0541	CbGbCtD
Tolazamide—KCNJ11—Gliclazide—type 2 diabetes mellitus	0.0083	0.0503	CbGbCtD
Tolazamide—ABCC8—Chlorpropamide—type 2 diabetes mellitus	0.00817	0.0495	CbGbCtD
Tolazamide—KCNJ11—Repaglinide—type 2 diabetes mellitus	0.00781	0.0473	CbGbCtD
Tolazamide—KCNJ1—Glyburide—type 2 diabetes mellitus	0.00769	0.0466	CbGbCtD
Tolazamide—ABCC8—Tolbutamide—type 2 diabetes mellitus	0.00728	0.0441	CbGbCtD
Tolazamide—KCNJ11—Chlorpropamide—type 2 diabetes mellitus	0.00706	0.0428	CbGbCtD
Tolazamide—KCNJ11—Tolbutamide—type 2 diabetes mellitus	0.00629	0.0381	CbGbCtD
Tolazamide—ABCC8—Nateglinide—type 2 diabetes mellitus	0.00619	0.0375	CbGbCtD
Tolazamide—Gliclazide—Glimepiride—type 2 diabetes mellitus	0.00587	0.0393	CrCrCtD
Tolazamide—Glipizide—Glimepiride—type 2 diabetes mellitus	0.00587	0.0393	CrCrCtD
Tolazamide—Tolbutamide—Glimepiride—type 2 diabetes mellitus	0.00587	0.0393	CrCrCtD
Tolazamide—Gliclazide—Glipizide—type 2 diabetes mellitus	0.00556	0.0373	CrCrCtD
Tolazamide—Tolbutamide—Glipizide—type 2 diabetes mellitus	0.00556	0.0373	CrCrCtD
Tolazamide—Glipizide—Gliclazide—type 2 diabetes mellitus	0.00556	0.0373	CrCrCtD
Tolazamide—Gliclazide—Tolbutamide—type 2 diabetes mellitus	0.00556	0.0373	CrCrCtD
Tolazamide—Glipizide—Tolbutamide—type 2 diabetes mellitus	0.00556	0.0373	CrCrCtD
Tolazamide—Tolbutamide—Gliclazide—type 2 diabetes mellitus	0.00556	0.0373	CrCrCtD
Tolazamide—KCNJ11—Nateglinide—type 2 diabetes mellitus	0.00535	0.0324	CbGbCtD
Tolazamide—Glisoxepide—Glimepiride—type 2 diabetes mellitus	0.00534	0.0358	CrCrCtD
Tolazamide—Glipizide—Chlorpropamide—type 2 diabetes mellitus	0.00509	0.0341	CrCrCtD
Tolazamide—Tolbutamide—Chlorpropamide—type 2 diabetes mellitus	0.00509	0.0341	CrCrCtD
Tolazamide—Gliclazide—Chlorpropamide—type 2 diabetes mellitus	0.00509	0.0341	CrCrCtD
Tolazamide—Glisoxepide—Glipizide—type 2 diabetes mellitus	0.00506	0.0339	CrCrCtD
Tolazamide—Glisoxepide—Tolbutamide—type 2 diabetes mellitus	0.00506	0.0339	CrCrCtD
Tolazamide—Glisoxepide—Gliclazide—type 2 diabetes mellitus	0.00506	0.0339	CrCrCtD
Tolazamide—Chlorpropamide—Glimepiride—type 2 diabetes mellitus	0.00491	0.0329	CrCrCtD
Tolazamide—Glyburide—Glimepiride—type 2 diabetes mellitus	0.00491	0.0329	CrCrCtD
Tolazamide—Chlorpropamide—Glipizide—type 2 diabetes mellitus	0.00465	0.0312	CrCrCtD
Tolazamide—Chlorpropamide—Gliclazide—type 2 diabetes mellitus	0.00465	0.0312	CrCrCtD
Tolazamide—Glyburide—Glipizide—type 2 diabetes mellitus	0.00465	0.0312	CrCrCtD
Tolazamide—Chlorpropamide—Tolbutamide—type 2 diabetes mellitus	0.00465	0.0312	CrCrCtD
Tolazamide—Glyburide—Gliclazide—type 2 diabetes mellitus	0.00465	0.0312	CrCrCtD
Tolazamide—Glisoxepide—Chlorpropamide—type 2 diabetes mellitus	0.00463	0.031	CrCrCtD
Tolazamide—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.00426	0.0285	CrCrCtD
Tolazamide—ABCC8—Glyburide—type 2 diabetes mellitus	0.00418	0.0253	CbGbCtD
Tolazamide—Glipizide—Glyburide—type 2 diabetes mellitus	0.00386	0.0258	CrCrCtD
Tolazamide—Gliclazide—Glyburide—type 2 diabetes mellitus	0.00386	0.0258	CrCrCtD
Tolazamide—KCNJ11—Glyburide—type 2 diabetes mellitus	0.00361	0.0219	CbGbCtD
Tolazamide—Glisoxepide—Glyburide—type 2 diabetes mellitus	0.00351	0.0235	CrCrCtD
Tolazamide—Chlorpropamide—Glyburide—type 2 diabetes mellitus	0.00323	0.0216	CrCrCtD
Tolazamide—Sulfacetamide—Tolbutamide—type 2 diabetes mellitus	0.0021	0.0141	CrCrCtD
Tolazamide—Sulfacetamide—Gliclazide—type 2 diabetes mellitus	0.0021	0.0141	CrCrCtD
Tolazamide—Sulfacetamide—Chlorpropamide—type 2 diabetes mellitus	0.00192	0.0129	CrCrCtD
Tolazamide—ABCC8—penis—type 2 diabetes mellitus	0.00121	0.317	CbGeAlD
Tolazamide—KCNJ1—nephron tubule—type 2 diabetes mellitus	0.000386	0.101	CbGeAlD
Tolazamide—KCNJ1—kidney—type 2 diabetes mellitus	0.00034	0.0892	CbGeAlD
Tolazamide—KCNJ1—cortex of kidney—type 2 diabetes mellitus	0.000331	0.0868	CbGeAlD
Tolazamide—KCNJ11—islet of Langerhans—type 2 diabetes mellitus	0.000291	0.0764	CbGeAlD
Tolazamide—ABCC8—islet of Langerhans—type 2 diabetes mellitus	0.000268	0.0704	CbGeAlD
Tolazamide—KCNJ11—cardiovascular system—type 2 diabetes mellitus	0.000211	0.0553	CbGeAlD
Tolazamide—KCNJ11—pancreas—type 2 diabetes mellitus	0.000205	0.0537	CbGeAlD
Tolazamide—ABCC8—cardiovascular system—type 2 diabetes mellitus	0.000194	0.0509	CbGeAlD
Tolazamide—ABCC8—kidney—type 2 diabetes mellitus	0.00019	0.0498	CbGeAlD
Tolazamide—ABCC8—pancreas—type 2 diabetes mellitus	0.000189	0.0495	CbGeAlD
Tolazamide—Glisoxepide—ABCC8—type 2 diabetes mellitus	0.000112	0.108	CrCbGaD
Tolazamide—Glipizide—ABCC8—type 2 diabetes mellitus	9.53e-05	0.0926	CrCbGaD
Tolazamide—Gliclazide—ABCC8—type 2 diabetes mellitus	8.86e-05	0.0861	CrCbGaD
Tolazamide—Glisoxepide—KCNJ11—type 2 diabetes mellitus	7.86e-05	0.0764	CrCbGaD
Tolazamide—Chlorpropamide—ABCC8—type 2 diabetes mellitus	6.89e-05	0.067	CrCbGaD
Tolazamide—Tolbutamide—ABCC8—type 2 diabetes mellitus	6.72e-05	0.0653	CrCbGaD
Tolazamide—Glipizide—KCNJ11—type 2 diabetes mellitus	6.72e-05	0.0653	CrCbGaD
Tolazamide—Glyburide—CPT1A—type 2 diabetes mellitus	6.72e-05	0.0653	CrCbGaD
Tolazamide—Gliclazide—KCNJ11—type 2 diabetes mellitus	6.24e-05	0.0607	CrCbGaD
Tolazamide—Chlorpropamide—KCNJ11—type 2 diabetes mellitus	4.85e-05	0.0472	CrCbGaD
Tolazamide—Gliclazide—VEGFA—type 2 diabetes mellitus	4.84e-05	0.047	CrCbGaD
Tolazamide—KCNJ11—Integration of energy metabolism—SLC2A2—type 2 diabetes mellitus	4.83e-05	0.00334	CbGpPWpGaD
Tolazamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—APOA1—type 2 diabetes mellitus	4.79e-05	0.00331	CbGpPWpGaD
Tolazamide—KCNJ11—Regulation of insulin secretion—SLC2A1—type 2 diabetes mellitus	4.76e-05	0.00329	CbGpPWpGaD
Tolazamide—Tolbutamide—KCNJ11—type 2 diabetes mellitus	4.73e-05	0.046	CrCbGaD
Tolazamide—ABCC8—Regulation of insulin secretion—GCG—type 2 diabetes mellitus	4.71e-05	0.00325	CbGpPWpGaD
Tolazamide—Glyburide—ABCC8—type 2 diabetes mellitus	4.65e-05	0.0452	CrCbGaD
Tolazamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—APOA1—type 2 diabetes mellitus	4.64e-05	0.00321	CbGpPWpGaD
Tolazamide—KCNJ11—Regulation of insulin secretion—GCG—type 2 diabetes mellitus	4.56e-05	0.00315	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—KCNQ1—type 2 diabetes mellitus	4.54e-05	0.00314	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—KCNQ1—type 2 diabetes mellitus	4.4e-05	0.00304	CbGpPWpGaD
Tolazamide—ABCC8—Integration of energy metabolism—SNAP25—type 2 diabetes mellitus	4.27e-05	0.00295	CbGpPWpGaD
Tolazamide—KCNJ11—Integration of energy metabolism—SNAP25—type 2 diabetes mellitus	4.14e-05	0.00286	CbGpPWpGaD
Tolazamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—INS—type 2 diabetes mellitus	4.14e-05	0.00286	CbGpPWpGaD
Tolazamide—ABCC8—Integration of energy metabolism—ADRA2A—type 2 diabetes mellitus	4.06e-05	0.00281	CbGpPWpGaD
Tolazamide—ABCC8—Regulation of insulin secretion—GNB3—type 2 diabetes mellitus	4.06e-05	0.0028	CbGpPWpGaD
Tolazamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—INS—type 2 diabetes mellitus	4.01e-05	0.00277	CbGpPWpGaD
Tolazamide—KCNJ11—Integration of energy metabolism—ADRA2A—type 2 diabetes mellitus	3.94e-05	0.00272	CbGpPWpGaD
Tolazamide—KCNJ11—Regulation of insulin secretion—GNB3—type 2 diabetes mellitus	3.93e-05	0.00272	CbGpPWpGaD
Tolazamide—ABCC8—Integration of energy metabolism—SLC2A1—type 2 diabetes mellitus	3.86e-05	0.00267	CbGpPWpGaD
Tolazamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—type 2 diabetes mellitus	3.79e-05	0.00262	CbGpPWpGaD
Tolazamide—KCNJ1—Neuronal System—SNAP25—type 2 diabetes mellitus	3.79e-05	0.00262	CbGpPWpGaD
Tolazamide—KCNJ11—Type II diabetes mellitus—TNF—type 2 diabetes mellitus	3.78e-05	0.00261	CbGpPWpGaD
Tolazamide—KCNJ11—Integration of energy metabolism—SLC2A1—type 2 diabetes mellitus	3.74e-05	0.00258	CbGpPWpGaD
Tolazamide—Glipizide—PPARG—type 2 diabetes mellitus	3.72e-05	0.0362	CrCbGaD
Tolazamide—ABCC8—Integration of energy metabolism—GCG—type 2 diabetes mellitus	3.7e-05	0.00256	CbGpPWpGaD
Tolazamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—type 2 diabetes mellitus	3.68e-05	0.00254	CbGpPWpGaD
Tolazamide—ABCC8—Regulation of insulin secretion—ADCY5—type 2 diabetes mellitus	3.62e-05	0.0025	CbGpPWpGaD
Tolazamide—KCNJ11—Integration of energy metabolism—GCG—type 2 diabetes mellitus	3.59e-05	0.00248	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	3.52e-05	0.00243	CbGpPWpGaD
Tolazamide—KCNJ11—Regulation of insulin secretion—ADCY5—type 2 diabetes mellitus	3.51e-05	0.00242	CbGpPWpGaD
Tolazamide—Haemolytic anaemia—Losartan—type 2 diabetes mellitus	3.5e-05	0.000893	CcSEcCtD
Tolazamide—Pancytopenia—Gliclazide—type 2 diabetes mellitus	3.49e-05	0.00089	CcSEcCtD
Tolazamide—Urticaria—Acarbose—type 2 diabetes mellitus	3.48e-05	0.000888	CcSEcCtD
Tolazamide—Erythema—Glimepiride—type 2 diabetes mellitus	3.46e-05	0.000882	CcSEcCtD
Tolazamide—Ill-defined disorder—Glipizide—type 2 diabetes mellitus	3.44e-05	0.000877	CcSEcCtD
Tolazamide—Agranulocytosis—Glyburide—type 2 diabetes mellitus	3.41e-05	0.000869	CcSEcCtD
Tolazamide—Thrombocytopenia—Rosiglitazone—type 2 diabetes mellitus	3.39e-05	0.000863	CcSEcCtD
Tolazamide—Hyponatraemia—Irbesartan—type 2 diabetes mellitus	3.37e-05	0.00086	CcSEcCtD
Tolazamide—Abdominal distension—Orlistat—type 2 diabetes mellitus	3.36e-05	0.000857	CcSEcCtD
Tolazamide—Urticaria—Nateglinide—type 2 diabetes mellitus	3.36e-05	0.000856	CcSEcCtD
Tolazamide—Photosensitivity reaction—Gliclazide—type 2 diabetes mellitus	3.36e-05	0.000856	CcSEcCtD
Tolazamide—Malaise—Glipizide—type 2 diabetes mellitus	3.34e-05	0.000853	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—ABCC8—type 2 diabetes mellitus	3.34e-05	0.0023	CbGpPWpGaD
Tolazamide—Vertigo—Glipizide—type 2 diabetes mellitus	3.33e-05	0.000849	CcSEcCtD
Tolazamide—Leukopenia—Glipizide—type 2 diabetes mellitus	3.32e-05	0.000846	CcSEcCtD
Tolazamide—ABCC8—Potassium Channels—GNB3—type 2 diabetes mellitus	3.32e-05	0.00229	CbGpPWpGaD
Tolazamide—Nausea—Miglitol—type 2 diabetes mellitus	3.31e-05	0.000844	CcSEcCtD
Tolazamide—Ill-defined disorder—Pioglitazone—type 2 diabetes mellitus	3.3e-05	0.00084	CcSEcCtD
Tolazamide—Glyburide—KCNJ11—type 2 diabetes mellitus	3.28e-05	0.0319	CrCbGaD
Tolazamide—Hypoglycaemia—Losartan—type 2 diabetes mellitus	3.24e-05	0.000826	CcSEcCtD
Tolazamide—Pruritus—Chlorpropamide—type 2 diabetes mellitus	3.23e-05	0.000823	CcSEcCtD
Tolazamide—Dyspepsia—Repaglinide—type 2 diabetes mellitus	3.22e-05	0.000821	CcSEcCtD
Tolazamide—KCNJ11—Potassium Channels—GNB3—type 2 diabetes mellitus	3.22e-05	0.00222	CbGpPWpGaD
Tolazamide—Malaise—Pioglitazone—type 2 diabetes mellitus	3.2e-05	0.000817	CcSEcCtD
Tolazamide—Ill-defined disorder—Sitagliptin—type 2 diabetes mellitus	3.2e-05	0.000816	CcSEcCtD
Tolazamide—Vertigo—Pioglitazone—type 2 diabetes mellitus	3.19e-05	0.000814	CcSEcCtD
Tolazamide—ABCC8—Integration of energy metabolism—GNB3—type 2 diabetes mellitus	3.19e-05	0.0022	CbGpPWpGaD
Tolazamide—Hyponatraemia—Losartan—type 2 diabetes mellitus	3.17e-05	0.000809	CcSEcCtD
Tolazamide—Rash—Tolbutamide—type 2 diabetes mellitus	3.16e-05	0.000806	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	3.16e-05	0.000805	CcSEcCtD
Tolazamide—Headache—Tolbutamide—type 2 diabetes mellitus	3.14e-05	0.000801	CcSEcCtD
Tolazamide—Discomfort—Glipizide—type 2 diabetes mellitus	3.12e-05	0.000795	CcSEcCtD
Tolazamide—Malaise—Sitagliptin—type 2 diabetes mellitus	3.11e-05	0.000793	CcSEcCtD
Tolazamide—Vertigo—Sitagliptin—type 2 diabetes mellitus	3.1e-05	0.00079	CcSEcCtD
Tolazamide—Abdominal distension—Metformin—type 2 diabetes mellitus	3.1e-05	0.00079	CcSEcCtD
Tolazamide—Leukopenia—Glimepiride—type 2 diabetes mellitus	3.1e-05	0.00079	CcSEcCtD
Tolazamide—KCNJ11—Integration of energy metabolism—GNB3—type 2 diabetes mellitus	3.09e-05	0.00214	CbGpPWpGaD
Tolazamide—Photosensitivity reaction—Valsartan—type 2 diabetes mellitus	3.08e-05	0.000786	CcSEcCtD
Tolazamide—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	3.06e-05	0.00078	CcSEcCtD
Tolazamide—Asthenia—Nateglinide—type 2 diabetes mellitus	3.03e-05	0.000773	CcSEcCtD
Tolazamide—Dizziness—Chlorpropamide—type 2 diabetes mellitus	3.02e-05	0.000769	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—GAD2—type 2 diabetes mellitus	3.01e-05	0.00208	CbGpPWpGaD
Tolazamide—Haemolytic anaemia—Ramipril—type 2 diabetes mellitus	3e-05	0.000766	CcSEcCtD
Tolazamide—Pruritus—Nateglinide—type 2 diabetes mellitus	2.99e-05	0.000762	CcSEcCtD
Tolazamide—Discomfort—Pioglitazone—type 2 diabetes mellitus	2.99e-05	0.000762	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	2.98e-05	0.000761	CcSEcCtD
Tolazamide—Fatigue—Rosiglitazone—type 2 diabetes mellitus	2.98e-05	0.00076	CcSEcCtD
Tolazamide—Nausea—Tolbutamide—type 2 diabetes mellitus	2.98e-05	0.000759	CcSEcCtD
Tolazamide—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	2.96e-05	0.000755	CcSEcCtD
Tolazamide—Abdominal distension—Irbesartan—type 2 diabetes mellitus	2.92e-05	0.000745	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—GAD2—type 2 diabetes mellitus	2.92e-05	0.00201	CbGpPWpGaD
Tolazamide—Urticaria—Repaglinide—type 2 diabetes mellitus	2.91e-05	0.000741	CcSEcCtD
Tolazamide—Discomfort—Sitagliptin—type 2 diabetes mellitus	2.9e-05	0.00074	CcSEcCtD
Tolazamide—Rash—Chlorpropamide—type 2 diabetes mellitus	2.88e-05	0.000733	CcSEcCtD
Tolazamide—Headache—Chlorpropamide—type 2 diabetes mellitus	2.86e-05	0.000729	CcSEcCtD
Tolazamide—Erythema—Glyburide—type 2 diabetes mellitus	2.85e-05	0.000728	CcSEcCtD
Tolazamide—Rash—Linagliptin—type 2 diabetes mellitus	2.85e-05	0.000726	CcSEcCtD
Tolazamide—ABCC8—Integration of energy metabolism—ADCY5—type 2 diabetes mellitus	2.84e-05	0.00196	CbGpPWpGaD
Tolazamide—KCNJ1—Neuronal System—GNB3—type 2 diabetes mellitus	2.83e-05	0.00196	CbGpPWpGaD
Tolazamide—Headache—Linagliptin—type 2 diabetes mellitus	2.83e-05	0.000721	CcSEcCtD
Tolazamide—Vertigo—Bromocriptine—type 2 diabetes mellitus	2.8e-05	0.000715	CcSEcCtD
Tolazamide—Dizziness—Nateglinide—type 2 diabetes mellitus	2.79e-05	0.000713	CcSEcCtD
Tolazamide—Hypoglycaemia—Ramipril—type 2 diabetes mellitus	2.78e-05	0.000708	CcSEcCtD
Tolazamide—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	2.77e-05	0.000705	CcSEcCtD
Tolazamide—Rash—Acarbose—type 2 diabetes mellitus	2.76e-05	0.000705	CcSEcCtD
Tolazamide—KCNJ11—Integration of energy metabolism—ADCY5—type 2 diabetes mellitus	2.76e-05	0.0019	CbGpPWpGaD
Tolazamide—Urticaria—Rosiglitazone—type 2 diabetes mellitus	2.75e-05	0.0007	CcSEcCtD
Tolazamide—ABCC8—Integration of energy metabolism—PPP2CA—type 2 diabetes mellitus	2.72e-05	0.00188	CbGpPWpGaD
Tolazamide—Hyponatraemia—Ramipril—type 2 diabetes mellitus	2.72e-05	0.000694	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—KCNJ11—type 2 diabetes mellitus	2.72e-05	0.00188	CbGpPWpGaD
Tolazamide—Nausea—Chlorpropamide—type 2 diabetes mellitus	2.71e-05	0.000691	CcSEcCtD
Tolazamide—Rash—Nateglinide—type 2 diabetes mellitus	2.66e-05	0.000679	CcSEcCtD
Tolazamide—Dyspepsia—Glipizide—type 2 diabetes mellitus	2.66e-05	0.000679	CcSEcCtD
Tolazamide—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	2.65e-05	0.000676	CcSEcCtD
Tolazamide—ABCC8—Regulation of insulin secretion—INS—type 2 diabetes mellitus	2.64e-05	0.00183	CbGpPWpGaD
Tolazamide—KCNJ11—Integration of energy metabolism—PPP2CA—type 2 diabetes mellitus	2.64e-05	0.00182	CbGpPWpGaD
Tolazamide—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	2.61e-05	0.000666	CcSEcCtD
Tolazamide—Nausea—Acarbose—type 2 diabetes mellitus	2.6e-05	0.000664	CcSEcCtD
Tolazamide—Pruritus—Repaglinide—type 2 diabetes mellitus	2.59e-05	0.00066	CcSEcCtD
Tolazamide—KCNJ11—Regulation of insulin secretion—INS—type 2 diabetes mellitus	2.56e-05	0.00177	CbGpPWpGaD
Tolazamide—Erythema—Gliclazide—type 2 diabetes mellitus	2.56e-05	0.000653	CcSEcCtD
Tolazamide—Leukopenia—Glyburide—type 2 diabetes mellitus	2.55e-05	0.000651	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—ADCY5—type 2 diabetes mellitus	2.53e-05	0.00174	CbGpPWpGaD
Tolazamide—Nausea—Nateglinide—type 2 diabetes mellitus	2.51e-05	0.00064	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	2.5e-05	0.000638	CcSEcCtD
Tolazamide—Fatigue—Pioglitazone—type 2 diabetes mellitus	2.5e-05	0.000637	CcSEcCtD
Tolazamide—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	2.49e-05	0.000636	CcSEcCtD
Tolazamide—Feeling abnormal—Glipizide—type 2 diabetes mellitus	2.49e-05	0.000636	CcSEcCtD
Tolazamide—Dyspepsia—Glimepiride—type 2 diabetes mellitus	2.49e-05	0.000634	CcSEcCtD
Tolazamide—Asthenia—Rosiglitazone—type 2 diabetes mellitus	2.48e-05	0.000632	CcSEcCtD
Tolazamide—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	2.48e-05	0.000632	CcSEcCtD
Tolazamide—Pruritus—Rosiglitazone—type 2 diabetes mellitus	2.45e-05	0.000624	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	2.44e-05	0.000622	CcSEcCtD
Tolazamide—Fatigue—Glimepiride—type 2 diabetes mellitus	2.44e-05	0.000621	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	2.43e-05	0.00062	CcSEcCtD
Tolazamide—Fatigue—Sitagliptin—type 2 diabetes mellitus	2.43e-05	0.000619	CcSEcCtD
Tolazamide—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	2.42e-05	0.000616	CcSEcCtD
Tolazamide—Urticaria—Glipizide—type 2 diabetes mellitus	2.4e-05	0.000613	CcSEcCtD
Tolazamide—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	2.39e-05	0.000609	CcSEcCtD
Tolazamide—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	2.38e-05	0.000606	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	2.35e-05	0.00162	CbGpPWpGaD
Tolazamide—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	2.33e-05	0.000593	CcSEcCtD
Tolazamide—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	2.32e-05	0.000591	CcSEcCtD
Tolazamide—Malaise—Gliclazide—type 2 diabetes mellitus	2.31e-05	0.000589	CcSEcCtD
Tolazamide—Rash—Repaglinide—type 2 diabetes mellitus	2.31e-05	0.000588	CcSEcCtD
Tolazamide—Urticaria—Pioglitazone—type 2 diabetes mellitus	2.3e-05	0.000587	CcSEcCtD
Tolazamide—Leukopenia—Gliclazide—type 2 diabetes mellitus	2.29e-05	0.000585	CcSEcCtD
Tolazamide—Headache—Repaglinide—type 2 diabetes mellitus	2.29e-05	0.000584	CcSEcCtD
Tolazamide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	2.29e-05	0.000583	CcSEcCtD
Tolazamide—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	2.28e-05	0.000581	CcSEcCtD
Tolazamide—Agranulocytosis—Losartan—type 2 diabetes mellitus	2.27e-05	0.00058	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.27e-05	0.00157	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.27e-05	0.00157	CbGpPWpGaD
Tolazamide—Urticaria—Glimepiride—type 2 diabetes mellitus	2.24e-05	0.000572	CcSEcCtD
Tolazamide—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	2.24e-05	0.000572	CcSEcCtD
Tolazamide—Urticaria—Sitagliptin—type 2 diabetes mellitus	2.24e-05	0.00057	CcSEcCtD
Tolazamide—Pancytopenia—Ramipril—type 2 diabetes mellitus	2.23e-05	0.000567	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	2.2e-05	0.000561	CcSEcCtD
Tolazamide—Fatigue—Bromocriptine—type 2 diabetes mellitus	2.2e-05	0.00056	CcSEcCtD
Tolazamide—Rash—Rosiglitazone—type 2 diabetes mellitus	2.18e-05	0.000556	CcSEcCtD
Tolazamide—Nausea—Repaglinide—type 2 diabetes mellitus	2.17e-05	0.000554	CcSEcCtD
Tolazamide—Asthenia—Glipizide—type 2 diabetes mellitus	2.17e-05	0.000554	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—CALM1—type 2 diabetes mellitus	2.17e-05	0.0015	CbGpPWpGaD
Tolazamide—Headache—Rosiglitazone—type 2 diabetes mellitus	2.17e-05	0.000552	CcSEcCtD
Tolazamide—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	2.16e-05	0.00055	CcSEcCtD
Tolazamide—Discomfort—Gliclazide—type 2 diabetes mellitus	2.16e-05	0.00055	CcSEcCtD
Tolazamide—Erythema—Metformin—type 2 diabetes mellitus	2.14e-05	0.000547	CcSEcCtD
Tolazamide—Pruritus—Glipizide—type 2 diabetes mellitus	2.14e-05	0.000546	CcSEcCtD
Tolazamide—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	2.14e-05	0.000545	CcSEcCtD
Tolazamide—Vertigo—Valsartan—type 2 diabetes mellitus	2.12e-05	0.000539	CcSEcCtD
Tolazamide—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	2.1e-05	0.000535	CcSEcCtD
Tolazamide—Malaise—Orlistat—type 2 diabetes mellitus	2.1e-05	0.000535	CcSEcCtD
Tolazamide—Vertigo—Orlistat—type 2 diabetes mellitus	2.09e-05	0.000533	CcSEcCtD
Tolazamide—Asthenia—Pioglitazone—type 2 diabetes mellitus	2.08e-05	0.00053	CcSEcCtD
Tolazamide—ABCC8—Integration of energy metabolism—INS—type 2 diabetes mellitus	2.08e-05	0.00144	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.08e-05	0.00143	CbGpPWpGaD
Tolazamide—Nausea—Rosiglitazone—type 2 diabetes mellitus	2.05e-05	0.000524	CcSEcCtD
Tolazamide—Dyspepsia—Glyburide—type 2 diabetes mellitus	2.05e-05	0.000523	CcSEcCtD
Tolazamide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	2.05e-05	0.000522	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—PRKCB—type 2 diabetes mellitus	2.04e-05	0.00141	CbGpPWpGaD
Tolazamide—Asthenia—Glimepiride—type 2 diabetes mellitus	2.03e-05	0.000517	CcSEcCtD
Tolazamide—Urticaria—Bromocriptine—type 2 diabetes mellitus	2.02e-05	0.000516	CcSEcCtD
Tolazamide—Erythema—Irbesartan—type 2 diabetes mellitus	2.02e-05	0.000516	CcSEcCtD
Tolazamide—Asthenia—Sitagliptin—type 2 diabetes mellitus	2.02e-05	0.000515	CcSEcCtD
Tolazamide—KCNJ11—Integration of energy metabolism—INS—type 2 diabetes mellitus	2.02e-05	0.00139	CbGpPWpGaD
Tolazamide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	2.01e-05	0.000513	CcSEcCtD
Tolazamide—Dizziness—Glipizide—type 2 diabetes mellitus	2e-05	0.00051	CcSEcCtD
Tolazamide—Pruritus—Glimepiride—type 2 diabetes mellitus	2e-05	0.000509	CcSEcCtD
Tolazamide—Ill-defined disorder—Metformin—type 2 diabetes mellitus	1.99e-05	0.000507	CcSEcCtD
Tolazamide—Discomfort—Orlistat—type 2 diabetes mellitus	1.96e-05	0.000499	CcSEcCtD
Tolazamide—Agranulocytosis—Ramipril—type 2 diabetes mellitus	1.95e-05	0.000497	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—SNAP25—type 2 diabetes mellitus	1.94e-05	0.00134	CbGpPWpGaD
Tolazamide—Malaise—Metformin—type 2 diabetes mellitus	1.93e-05	0.000493	CcSEcCtD
Tolazamide—Feeling abnormal—Glyburide—type 2 diabetes mellitus	1.92e-05	0.000489	CcSEcCtD
Tolazamide—Dizziness—Pioglitazone—type 2 diabetes mellitus	1.92e-05	0.000489	CcSEcCtD
Tolazamide—Rash—Glipizide—type 2 diabetes mellitus	1.91e-05	0.000486	CcSEcCtD
Tolazamide—Erythema—Losartan—type 2 diabetes mellitus	1.9e-05	0.000485	CcSEcCtD
Tolazamide—Headache—Glipizide—type 2 diabetes mellitus	1.9e-05	0.000483	CcSEcCtD
Tolazamide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	1.88e-05	0.00048	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—SNAP25—type 2 diabetes mellitus	1.88e-05	0.0013	CbGpPWpGaD
Tolazamide—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	1.88e-05	0.000479	CcSEcCtD
Tolazamide—Dizziness—Glimepiride—type 2 diabetes mellitus	1.87e-05	0.000476	CcSEcCtD
Tolazamide—Dizziness—Sitagliptin—type 2 diabetes mellitus	1.86e-05	0.000475	CcSEcCtD
Tolazamide—Urticaria—Glyburide—type 2 diabetes mellitus	1.85e-05	0.000472	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	1.85e-05	0.00128	CbGpPWpGaD
Tolazamide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	1.84e-05	0.000469	CcSEcCtD
Tolazamide—Asthenia—Bromocriptine—type 2 diabetes mellitus	1.83e-05	0.000466	CcSEcCtD
Tolazamide—Malaise—Irbesartan—type 2 diabetes mellitus	1.82e-05	0.000465	CcSEcCtD
Tolazamide—Vertigo—Irbesartan—type 2 diabetes mellitus	1.82e-05	0.000463	CcSEcCtD
Tolazamide—Headache—Pioglitazone—type 2 diabetes mellitus	1.82e-05	0.000463	CcSEcCtD
Tolazamide—Leukopenia—Irbesartan—type 2 diabetes mellitus	1.81e-05	0.000462	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	1.81e-05	0.00046	CcSEcCtD
Tolazamide—Discomfort—Metformin—type 2 diabetes mellitus	1.8e-05	0.00046	CcSEcCtD
Tolazamide—Fatigue—Gliclazide—type 2 diabetes mellitus	1.8e-05	0.00046	CcSEcCtD
Tolazamide—Nausea—Glipizide—type 2 diabetes mellitus	1.8e-05	0.000458	CcSEcCtD
Tolazamide—Rash—Glimepiride—type 2 diabetes mellitus	1.78e-05	0.000454	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	1.78e-05	0.00123	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	1.78e-05	0.00123	CbGpPWpGaD
Tolazamide—Rash—Sitagliptin—type 2 diabetes mellitus	1.78e-05	0.000453	CcSEcCtD
Tolazamide—Glyburide—ABCC2—type 2 diabetes mellitus	1.77e-05	0.0172	CrCbGaD
Tolazamide—Headache—Glimepiride—type 2 diabetes mellitus	1.77e-05	0.000451	CcSEcCtD
Tolazamide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	1.77e-05	0.00045	CcSEcCtD
Tolazamide—Headache—Sitagliptin—type 2 diabetes mellitus	1.76e-05	0.00045	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	1.75e-05	0.00121	CbGpPWpGaD
Tolazamide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	1.72e-05	0.000439	CcSEcCtD
Tolazamide—Malaise—Losartan—type 2 diabetes mellitus	1.72e-05	0.000438	CcSEcCtD
Tolazamide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	1.71e-05	0.000437	CcSEcCtD
Tolazamide—Vertigo—Losartan—type 2 diabetes mellitus	1.71e-05	0.000436	CcSEcCtD
Tolazamide—Leukopenia—Losartan—type 2 diabetes mellitus	1.7e-05	0.000435	CcSEcCtD
Tolazamide—Discomfort—Irbesartan—type 2 diabetes mellitus	1.7e-05	0.000434	CcSEcCtD
Tolazamide—Dyspepsia—Valsartan—type 2 diabetes mellitus	1.69e-05	0.000431	CcSEcCtD
Tolazamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	1.68e-05	0.00043	CcSEcCtD
Tolazamide—Nausea—Glimepiride—type 2 diabetes mellitus	1.68e-05	0.000428	CcSEcCtD
Tolazamide—Nausea—Sitagliptin—type 2 diabetes mellitus	1.67e-05	0.000426	CcSEcCtD
Tolazamide—Dyspepsia—Orlistat—type 2 diabetes mellitus	1.67e-05	0.000426	CcSEcCtD
Tolazamide—Asthenia—Glyburide—type 2 diabetes mellitus	1.67e-05	0.000426	CcSEcCtD
Tolazamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	1.67e-05	0.00115	CbGpPWpGaD
Tolazamide—Urticaria—Gliclazide—type 2 diabetes mellitus	1.66e-05	0.000424	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	1.66e-05	0.000423	CcSEcCtD
Tolazamide—Fatigue—Valsartan—type 2 diabetes mellitus	1.66e-05	0.000422	CcSEcCtD
Tolazamide—Pruritus—Glyburide—type 2 diabetes mellitus	1.65e-05	0.00042	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	1.64e-05	0.000418	CcSEcCtD
Tolazamide—Fatigue—Orlistat—type 2 diabetes mellitus	1.64e-05	0.000417	CcSEcCtD
Tolazamide—Erythema—Ramipril—type 2 diabetes mellitus	1.63e-05	0.000416	CcSEcCtD
Tolazamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	1.62e-05	0.00112	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	1.62e-05	0.00112	CbGpPWpGaD
Tolazamide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	1.62e-05	0.000412	CcSEcCtD
Tolazamide—Rash—Bromocriptine—type 2 diabetes mellitus	1.61e-05	0.00041	CcSEcCtD
Tolazamide—Glipizide—CYP3A4—type 2 diabetes mellitus	1.6e-05	0.0156	CrCbGaD
Tolazamide—Discomfort—Losartan—type 2 diabetes mellitus	1.6e-05	0.000408	CcSEcCtD
Tolazamide—Headache—Bromocriptine—type 2 diabetes mellitus	1.6e-05	0.000407	CcSEcCtD
Tolazamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	1.56e-05	0.000399	CcSEcCtD
Tolazamide—Dyspepsia—Metformin—type 2 diabetes mellitus	1.54e-05	0.000393	CcSEcCtD
Tolazamide—Urticaria—Valsartan—type 2 diabetes mellitus	1.53e-05	0.000389	CcSEcCtD
Tolazamide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	1.52e-05	0.000388	CcSEcCtD
Tolazamide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	1.51e-05	0.000386	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.51e-05	0.00105	CbGpPWpGaD
Tolazamide—Nausea—Bromocriptine—type 2 diabetes mellitus	1.51e-05	0.000386	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	1.51e-05	0.000385	CcSEcCtD
Tolazamide—Fatigue—Metformin—type 2 diabetes mellitus	1.51e-05	0.000385	CcSEcCtD
Tolazamide—ABCC8—Metabolism—BHMT—type 2 diabetes mellitus	1.51e-05	0.00104	CbGpPWpGaD
Tolazamide—Urticaria—Orlistat—type 2 diabetes mellitus	1.51e-05	0.000385	CcSEcCtD
Tolazamide—Asthenia—Gliclazide—type 2 diabetes mellitus	1.5e-05	0.000383	CcSEcCtD
Tolazamide—Pruritus—Gliclazide—type 2 diabetes mellitus	1.48e-05	0.000377	CcSEcCtD
Tolazamide—Malaise—Ramipril—type 2 diabetes mellitus	1.47e-05	0.000375	CcSEcCtD
Tolazamide—Rash—Glyburide—type 2 diabetes mellitus	1.47e-05	0.000374	CcSEcCtD
Tolazamide—Vertigo—Ramipril—type 2 diabetes mellitus	1.47e-05	0.000374	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—BHMT—type 2 diabetes mellitus	1.46e-05	0.00101	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.46e-05	0.00101	CbGpPWpGaD
Tolazamide—Leukopenia—Ramipril—type 2 diabetes mellitus	1.46e-05	0.000373	CcSEcCtD
Tolazamide—Headache—Glyburide—type 2 diabetes mellitus	1.46e-05	0.000372	CcSEcCtD
Tolazamide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	1.45e-05	0.000371	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—GNB3—type 2 diabetes mellitus	1.45e-05	0.001	CbGpPWpGaD
Tolazamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	1.44e-05	0.000368	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	1.43e-05	0.000363	CcSEcCtD
Tolazamide—Fatigue—Irbesartan—type 2 diabetes mellitus	1.42e-05	0.000363	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—GNB3—type 2 diabetes mellitus	1.4e-05	0.00097	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.4e-05	0.000968	CbGpPWpGaD
Tolazamide—Urticaria—Metformin—type 2 diabetes mellitus	1.39e-05	0.000354	CcSEcCtD
Tolazamide—Nausea—Glyburide—type 2 diabetes mellitus	1.38e-05	0.000353	CcSEcCtD
Tolazamide—Dizziness—Gliclazide—type 2 diabetes mellitus	1.38e-05	0.000353	CcSEcCtD
Tolazamide—Asthenia—Valsartan—type 2 diabetes mellitus	1.38e-05	0.000351	CcSEcCtD
Tolazamide—Discomfort—Ramipril—type 2 diabetes mellitus	1.37e-05	0.00035	CcSEcCtD
Tolazamide—Dyspepsia—Losartan—type 2 diabetes mellitus	1.37e-05	0.000349	CcSEcCtD
Tolazamide—Asthenia—Orlistat—type 2 diabetes mellitus	1.36e-05	0.000347	CcSEcCtD
Tolazamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	1.36e-05	0.000347	CcSEcCtD
Tolazamide—Pruritus—Valsartan—type 2 diabetes mellitus	1.36e-05	0.000347	CcSEcCtD
Tolazamide—Pruritus—Orlistat—type 2 diabetes mellitus	1.34e-05	0.000342	CcSEcCtD
Tolazamide—Fatigue—Losartan—type 2 diabetes mellitus	1.34e-05	0.000342	CcSEcCtD
Tolazamide—Rash—Gliclazide—type 2 diabetes mellitus	1.32e-05	0.000336	CcSEcCtD
Tolazamide—ABCC8—Metabolism—AANAT—type 2 diabetes mellitus	1.32e-05	0.000911	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PTGDS—type 2 diabetes mellitus	1.32e-05	0.000911	CbGpPWpGaD
Tolazamide—Urticaria—Irbesartan—type 2 diabetes mellitus	1.31e-05	0.000334	CcSEcCtD
Tolazamide—Headache—Gliclazide—type 2 diabetes mellitus	1.31e-05	0.000334	CcSEcCtD
Tolazamide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	1.3e-05	0.000333	CcSEcCtD
Tolazamide—Gliclazide—ALB—type 2 diabetes mellitus	1.3e-05	0.0126	CrCbGaD
Tolazamide—ABCC8—Neuronal System—ADCY5—type 2 diabetes mellitus	1.29e-05	0.000891	CbGpPWpGaD
Tolazamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	1.28e-05	0.000326	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—PTGDS—type 2 diabetes mellitus	1.28e-05	0.000883	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AANAT—type 2 diabetes mellitus	1.28e-05	0.000883	CbGpPWpGaD
Tolazamide—Dizziness—Valsartan—type 2 diabetes mellitus	1.27e-05	0.000324	CcSEcCtD
Tolazamide—Dizziness—Orlistat—type 2 diabetes mellitus	1.26e-05	0.00032	CcSEcCtD
Tolazamide—Asthenia—Metformin—type 2 diabetes mellitus	1.26e-05	0.00032	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—ADCY5—type 2 diabetes mellitus	1.25e-05	0.000864	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CDO1—type 2 diabetes mellitus	1.25e-05	0.000863	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GPD2—type 2 diabetes mellitus	1.25e-05	0.000863	CbGpPWpGaD
Tolazamide—Nausea—Gliclazide—type 2 diabetes mellitus	1.24e-05	0.000317	CcSEcCtD
Tolazamide—Pruritus—Metformin—type 2 diabetes mellitus	1.24e-05	0.000316	CcSEcCtD
Tolazamide—Urticaria—Losartan—type 2 diabetes mellitus	1.23e-05	0.000315	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.22e-05	0.00084	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GPD2—type 2 diabetes mellitus	1.21e-05	0.000837	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CDO1—type 2 diabetes mellitus	1.21e-05	0.000837	CbGpPWpGaD
Tolazamide—Rash—Valsartan—type 2 diabetes mellitus	1.21e-05	0.000309	CcSEcCtD
Tolazamide—Headache—Valsartan—type 2 diabetes mellitus	1.2e-05	0.000307	CcSEcCtD
Tolazamide—Rash—Orlistat—type 2 diabetes mellitus	1.2e-05	0.000305	CcSEcCtD
Tolazamide—ABCC8—Metabolism—AK1—type 2 diabetes mellitus	1.19e-05	0.000823	CbGpPWpGaD
Tolazamide—Headache—Orlistat—type 2 diabetes mellitus	1.19e-05	0.000303	CcSEcCtD
Tolazamide—Asthenia—Irbesartan—type 2 diabetes mellitus	1.18e-05	0.000302	CcSEcCtD
Tolazamide—Dyspepsia—Ramipril—type 2 diabetes mellitus	1.17e-05	0.000299	CcSEcCtD
Tolazamide—Pruritus—Irbesartan—type 2 diabetes mellitus	1.17e-05	0.000298	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.16e-05	0.000802	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.16e-05	0.000802	CbGpPWpGaD
Tolazamide—Dizziness—Metformin—type 2 diabetes mellitus	1.16e-05	0.000295	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—AK1—type 2 diabetes mellitus	1.16e-05	0.000798	CbGpPWpGaD
Tolazamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	1.15e-05	0.000293	CcSEcCtD
Tolazamide—Fatigue—Ramipril—type 2 diabetes mellitus	1.15e-05	0.000293	CcSEcCtD
Tolazamide—Nausea—Valsartan—type 2 diabetes mellitus	1.14e-05	0.000291	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.13e-05	0.000783	CbGpPWpGaD
Tolazamide—Nausea—Orlistat—type 2 diabetes mellitus	1.13e-05	0.000288	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.13e-05	0.000778	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.12e-05	0.000774	CbGpPWpGaD
Tolazamide—Asthenia—Losartan—type 2 diabetes mellitus	1.12e-05	0.000284	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—CALM1—type 2 diabetes mellitus	1.11e-05	0.000766	CbGpPWpGaD
Tolazamide—Rash—Metformin—type 2 diabetes mellitus	1.1e-05	0.000281	CcSEcCtD
Tolazamide—ABCC8—Metabolism—SLC5A4—type 2 diabetes mellitus	1.1e-05	0.00076	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—MAT1A—type 2 diabetes mellitus	1.1e-05	0.00076	CbGpPWpGaD
Tolazamide—Pruritus—Losartan—type 2 diabetes mellitus	1.1e-05	0.00028	CcSEcCtD
Tolazamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.1e-05	0.00028	CcSEcCtD
Tolazamide—Headache—Metformin—type 2 diabetes mellitus	1.1e-05	0.000279	CcSEcCtD
Tolazamide—Dizziness—Irbesartan—type 2 diabetes mellitus	1.09e-05	0.000278	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—CALM1—type 2 diabetes mellitus	1.08e-05	0.000743	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—MAT1A—type 2 diabetes mellitus	1.07e-05	0.000737	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SLC5A4—type 2 diabetes mellitus	1.07e-05	0.000737	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ND1—type 2 diabetes mellitus	1.06e-05	0.000734	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.06e-05	0.000734	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—G6PC—type 2 diabetes mellitus	1.06e-05	0.000734	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HBA2—type 2 diabetes mellitus	1.06e-05	0.000734	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ENPP1—type 2 diabetes mellitus	1.06e-05	0.000734	CbGpPWpGaD
Tolazamide—Urticaria—Ramipril—type 2 diabetes mellitus	1.06e-05	0.00027	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—PRKCB—type 2 diabetes mellitus	1.04e-05	0.00072	CbGpPWpGaD
Tolazamide—Rash—Irbesartan—type 2 diabetes mellitus	1.04e-05	0.000265	CcSEcCtD
Tolazamide—Nausea—Metformin—type 2 diabetes mellitus	1.04e-05	0.000265	CcSEcCtD
Tolazamide—Headache—Irbesartan—type 2 diabetes mellitus	1.03e-05	0.000264	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.03e-05	0.000712	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HBA2—type 2 diabetes mellitus	1.03e-05	0.000712	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ENPP1—type 2 diabetes mellitus	1.03e-05	0.000712	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—G6PC—type 2 diabetes mellitus	1.03e-05	0.000712	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ND1—type 2 diabetes mellitus	1.03e-05	0.000712	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GCGR—type 2 diabetes mellitus	1.03e-05	0.000711	CbGpPWpGaD
Tolazamide—Dizziness—Losartan—type 2 diabetes mellitus	1.03e-05	0.000262	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—PRKCB—type 2 diabetes mellitus	1.01e-05	0.000698	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GCGR—type 2 diabetes mellitus	9.98e-06	0.000689	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	9.88e-06	0.000682	CbGpPWpGaD
Tolazamide—Nausea—Irbesartan—type 2 diabetes mellitus	9.81e-06	0.00025	CcSEcCtD
Tolazamide—Rash—Losartan—type 2 diabetes mellitus	9.8e-06	0.00025	CcSEcCtD
Tolazamide—Headache—Losartan—type 2 diabetes mellitus	9.74e-06	0.000248	CcSEcCtD
Tolazamide—ABCC8—Metabolism—OXCT1—type 2 diabetes mellitus	9.72e-06	0.000671	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYTB—type 2 diabetes mellitus	9.72e-06	0.000671	CbGpPWpGaD
Tolazamide—Asthenia—Ramipril—type 2 diabetes mellitus	9.56e-06	0.000244	CcSEcCtD
Tolazamide—ABCC8—Metabolism—SRD5A1—type 2 diabetes mellitus	9.47e-06	0.000654	CbGpPWpGaD
Tolazamide—Pruritus—Ramipril—type 2 diabetes mellitus	9.43e-06	0.00024	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—OXCT1—type 2 diabetes mellitus	9.43e-06	0.000651	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYTB—type 2 diabetes mellitus	9.43e-06	0.000651	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	9.42e-06	0.000651	CbGpPWpGaD
Tolazamide—Nausea—Losartan—type 2 diabetes mellitus	9.23e-06	0.000235	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—SRD5A1—type 2 diabetes mellitus	9.19e-06	0.000634	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—STAR—type 2 diabetes mellitus	9.04e-06	0.000624	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HSD17B3—type 2 diabetes mellitus	9.04e-06	0.000624	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ACACA—type 2 diabetes mellitus	9.04e-06	0.000624	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	9.03e-06	0.000624	CbGpPWpGaD
Tolazamide—Dizziness—Ramipril—type 2 diabetes mellitus	8.81e-06	0.000225	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—STAR—type 2 diabetes mellitus	8.76e-06	0.000605	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HSD17B3—type 2 diabetes mellitus	8.76e-06	0.000605	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ACACA—type 2 diabetes mellitus	8.76e-06	0.000605	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CBS—type 2 diabetes mellitus	8.66e-06	0.000598	CbGpPWpGaD
Tolazamide—Rash—Ramipril—type 2 diabetes mellitus	8.4e-06	0.000214	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—CBS—type 2 diabetes mellitus	8.4e-06	0.00058	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ABCC8—type 2 diabetes mellitus	8.4e-06	0.00058	CbGpPWpGaD
Tolazamide—Headache—Ramipril—type 2 diabetes mellitus	8.35e-06	0.000213	CcSEcCtD
Tolazamide—ABCC8—Metabolism—SLC5A2—type 2 diabetes mellitus	8.34e-06	0.000576	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—COX2—type 2 diabetes mellitus	8.34e-06	0.000576	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NCOA6—type 2 diabetes mellitus	8.19e-06	0.000566	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SLC5A2—type 2 diabetes mellitus	8.09e-06	0.000558	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—COX2—type 2 diabetes mellitus	8.09e-06	0.000558	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HSD11B1—type 2 diabetes mellitus	8.05e-06	0.000556	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—UCP3—type 2 diabetes mellitus	8.05e-06	0.000556	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—UCP2—type 2 diabetes mellitus	8.05e-06	0.000556	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NCOA6—type 2 diabetes mellitus	7.94e-06	0.000549	CbGpPWpGaD
Tolazamide—Nausea—Ramipril—type 2 diabetes mellitus	7.92e-06	0.000202	CcSEcCtD
Tolazamide—Glyburide—CYP3A4—type 2 diabetes mellitus	7.84e-06	0.00761	CrCbGaD
Tolazamide—KCNJ11—Metabolism—UCP2—type 2 diabetes mellitus	7.81e-06	0.000539	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HSD11B1—type 2 diabetes mellitus	7.81e-06	0.000539	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—UCP3—type 2 diabetes mellitus	7.81e-06	0.000539	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	7.79e-06	0.000538	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	7.75e-06	0.000535	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	7.68e-06	0.00053	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PCK1—type 2 diabetes mellitus	7.57e-06	0.000523	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	7.42e-06	0.000513	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PCK1—type 2 diabetes mellitus	7.34e-06	0.000507	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HK1—type 2 diabetes mellitus	7.09e-06	0.00049	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	6.94e-06	0.000479	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HK1—type 2 diabetes mellitus	6.88e-06	0.000475	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HSD3B2—type 2 diabetes mellitus	6.85e-06	0.000473	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—KCNJ11—type 2 diabetes mellitus	6.85e-06	0.000473	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—LPA—type 2 diabetes mellitus	6.85e-06	0.000473	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GCKR—type 2 diabetes mellitus	6.85e-06	0.000473	CbGpPWpGaD
Tolazamide—Glyburide—ALB—type 2 diabetes mellitus	6.84e-06	0.00664	CrCbGaD
Tolazamide—KCNJ11—Metabolism—GCKR—type 2 diabetes mellitus	6.64e-06	0.000459	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HSD3B2—type 2 diabetes mellitus	6.64e-06	0.000459	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—LPA—type 2 diabetes mellitus	6.64e-06	0.000459	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ALDOB—type 2 diabetes mellitus	6.57e-06	0.000453	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ALDOB—type 2 diabetes mellitus	6.37e-06	0.00044	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	6.26e-06	0.000432	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GLP1R—type 2 diabetes mellitus	6.1e-06	0.000422	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GLP1R—type 2 diabetes mellitus	5.92e-06	0.000409	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.87e-06	0.000406	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SLC2A2—type 2 diabetes mellitus	5.7e-06	0.000394	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CPT1A—type 2 diabetes mellitus	5.58e-06	0.000386	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—MTR—type 2 diabetes mellitus	5.58e-06	0.000386	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SLC2A2—type 2 diabetes mellitus	5.53e-06	0.000382	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NAMPT—type 2 diabetes mellitus	5.48e-06	0.000378	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HBA1—type 2 diabetes mellitus	5.44e-06	0.000376	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—LIPC—type 2 diabetes mellitus	5.44e-06	0.000376	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GCK—type 2 diabetes mellitus	5.44e-06	0.000376	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CPT1A—type 2 diabetes mellitus	5.41e-06	0.000374	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—MTR—type 2 diabetes mellitus	5.41e-06	0.000374	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP11A1—type 2 diabetes mellitus	5.41e-06	0.000373	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SLC9A1—type 2 diabetes mellitus	5.31e-06	0.000367	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NAMPT—type 2 diabetes mellitus	5.31e-06	0.000367	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—LIPC—type 2 diabetes mellitus	5.28e-06	0.000364	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HBA1—type 2 diabetes mellitus	5.28e-06	0.000364	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GCK—type 2 diabetes mellitus	5.28e-06	0.000364	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CETP—type 2 diabetes mellitus	5.25e-06	0.000362	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP11A1—type 2 diabetes mellitus	5.24e-06	0.000362	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SLC9A1—type 2 diabetes mellitus	5.15e-06	0.000356	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CETP—type 2 diabetes mellitus	5.09e-06	0.000352	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PSMD6—type 2 diabetes mellitus	4.88e-06	0.000337	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SNAP25—type 2 diabetes mellitus	4.88e-06	0.000337	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SREBF1—type 2 diabetes mellitus	4.88e-06	0.000337	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CTGF—type 2 diabetes mellitus	4.79e-06	0.000331	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HMGCR—type 2 diabetes mellitus	4.75e-06	0.000328	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SNAP25—type 2 diabetes mellitus	4.73e-06	0.000327	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SREBF1—type 2 diabetes mellitus	4.73e-06	0.000327	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PSMD6—type 2 diabetes mellitus	4.73e-06	0.000327	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.65e-06	0.000321	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ADRA2A—type 2 diabetes mellitus	4.65e-06	0.000321	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CTGF—type 2 diabetes mellitus	4.64e-06	0.000321	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HMGCR—type 2 diabetes mellitus	4.6e-06	0.000318	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ADRA2A—type 2 diabetes mellitus	4.5e-06	0.000311	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP2E1—type 2 diabetes mellitus	4.46e-06	0.000308	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP1A2—type 2 diabetes mellitus	4.41e-06	0.000305	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SLC2A1—type 2 diabetes mellitus	4.41e-06	0.000305	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP2E1—type 2 diabetes mellitus	4.33e-06	0.000299	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP3A4—type 2 diabetes mellitus	4.3e-06	0.000297	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SLC2A1—type 2 diabetes mellitus	4.28e-06	0.000296	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP1A2—type 2 diabetes mellitus	4.28e-06	0.000296	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GCG—type 2 diabetes mellitus	4.23e-06	0.000292	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SLC2A4—type 2 diabetes mellitus	4.23e-06	0.000292	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP3A4—type 2 diabetes mellitus	4.17e-06	0.000288	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SLC2A4—type 2 diabetes mellitus	4.1e-06	0.000283	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GCG—type 2 diabetes mellitus	4.1e-06	0.000283	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GNB3—type 2 diabetes mellitus	3.65e-06	0.000252	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.65e-06	0.000252	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HMOX1—type 2 diabetes mellitus	3.63e-06	0.000251	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CAT—type 2 diabetes mellitus	3.58e-06	0.000247	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GNB3—type 2 diabetes mellitus	3.54e-06	0.000244	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.54e-06	0.000244	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HMOX1—type 2 diabetes mellitus	3.52e-06	0.000243	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—APOB—type 2 diabetes mellitus	3.48e-06	0.00024	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CAT—type 2 diabetes mellitus	3.47e-06	0.00024	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTM1—type 2 diabetes mellitus	3.38e-06	0.000234	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—APOB—type 2 diabetes mellitus	3.37e-06	0.000233	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—LPL—type 2 diabetes mellitus	3.32e-06	0.000229	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTM1—type 2 diabetes mellitus	3.28e-06	0.000227	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ADCY5—type 2 diabetes mellitus	3.25e-06	0.000224	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GPX1—type 2 diabetes mellitus	3.24e-06	0.000224	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—LPL—type 2 diabetes mellitus	3.22e-06	0.000222	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CD36—type 2 diabetes mellitus	3.15e-06	0.000218	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ADCY5—type 2 diabetes mellitus	3.15e-06	0.000218	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GPX1—type 2 diabetes mellitus	3.14e-06	0.000217	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.12e-06	0.000215	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CD36—type 2 diabetes mellitus	3.06e-06	0.000211	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PPP2CA—type 2 diabetes mellitus	3.02e-06	0.000209	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—MTHFR—type 2 diabetes mellitus	2.99e-06	0.000206	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PPARA—type 2 diabetes mellitus	2.93e-06	0.000203	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—MTHFR—type 2 diabetes mellitus	2.9e-06	0.0002	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PPARA—type 2 diabetes mellitus	2.84e-06	0.000196	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—AGT—type 2 diabetes mellitus	2.84e-06	0.000196	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CALM1—type 2 diabetes mellitus	2.79e-06	0.000193	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—APOE—type 2 diabetes mellitus	2.78e-06	0.000192	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AGT—type 2 diabetes mellitus	2.75e-06	0.00019	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—APOA1—type 2 diabetes mellitus	2.75e-06	0.00019	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CALM1—type 2 diabetes mellitus	2.71e-06	0.000187	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—APOE—type 2 diabetes mellitus	2.7e-06	0.000186	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—APOA1—type 2 diabetes mellitus	2.67e-06	0.000184	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PPARG—type 2 diabetes mellitus	2.42e-06	0.000167	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—INS—type 2 diabetes mellitus	2.38e-06	0.000164	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PPARG—type 2 diabetes mellitus	2.35e-06	0.000162	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—INS—type 2 diabetes mellitus	2.31e-06	0.000159	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ALB—type 2 diabetes mellitus	2.18e-06	0.000151	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ALB—type 2 diabetes mellitus	2.11e-06	0.000146	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.08e-06	0.000144	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NOS3—type 2 diabetes mellitus	2.08e-06	0.000144	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3R1—type 2 diabetes mellitus	2.02e-06	0.00014	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NOS3—type 2 diabetes mellitus	2.02e-06	0.00014	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PTGS2—type 2 diabetes mellitus	1.91e-06	0.000132	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PTGS2—type 2 diabetes mellitus	1.85e-06	0.000128	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—AKT1—type 2 diabetes mellitus	9.58e-07	6.62e-05	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AKT1—type 2 diabetes mellitus	9.29e-07	6.42e-05	CbGpPWpGaD
